Company page

Gemvax & Kael Co Ltd

Gemvax & Kael Co Ltd, traded under the ticker 082270, is a public company based in Korea with a market capitalization of approximately 463.3 million USD. The company is involved in the biotechnology sector, focusing on the development of innovative therapies. Investors can find more information about its operations and market performance on its official page.